TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target

Journal of Leukocyte Biology

Volumn 100, Issue 1, 2016, Pages 27-45

  Ullah, M Obayed ^a,c   Sweet, Matthew J ^a   Mansell, Ashley ^b   Kellie, Stuart ^a   Kobe, Bostjan ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c NORTH SOUTH UNIVERSITY   (Bangladesh)

Author keywords

Adaptor protein; Innate immunity; Pattern recognition receptor

Indexed keywords

TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TICAM1 PROTEIN, HUMAN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

CARDIOVASCULAR DISEASE; CELL DEATH; ENTERITIS; HOST RESISTANCE; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; INTESTINE INFECTION; LIVER DISEASE; LUNG INFECTION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; RESPIRATORY TRACT INFECTION; REVIEW; SYSTEMIC DISEASE; TLR SIGNALING; VIRUS INFECTION; GENE EXPRESSION REGULATION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 85018970775     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.2RI1115-531R     Document Type: Review

References (240)

1. Janeway, Jr., C. A. (1989) Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54, 1-13.
2. Matzinger, P. (1994) Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045.
3. Gay, N. J., Keith, F. J. (1991) Drosophila Toll and IL-1 receptor. Nature 351, 355-356.
4. O’Neill, L. A., Bowie, A. G. (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7, 353-364.
5. Gay, N. J., Gangloff, M. (2007) Structure and function of Toll receptors and their ligands. Annu. Rev. Biochem. 76, 141-165.
6. Akira, S., Uematsu, S., Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell 124, 783-801.
7. Kawai, T., Akira, S. (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384.
8. Sotolongo, J., España, C., Echeverry, A., Siefker, D., Altman, N., Zaias, J., Santaolalla, R., Ruiz, J., Schesser, K., Adkins, B., Fukata, M. (2011) Host innate recognition of an intestinal bacterial pathogen induces TRIF-dependent protective immunity. J. Exp. Med. 208, 2705-2716.
9. Brikos, C., O’Neill, L. A. (2008) Signalling of Toll-like receptors. Handb. Exp. Pharmacol. 21-50.
10. Jenkins, K. A., Mansell, A. (2010) TIR-containing adaptors in Toll-like receptor signalling. Cytokine 49, 237-244.
11. Ve, T., Gay, N. J., Mansell, A., Kobe, B., Kellie, S. (2012) Adaptors in Toll-like receptor signaling and their potential as therapeutic targets. Curr. Drug Targets 13, 1360-1374.
12. Troutman, T. D., Hu, W., Fulenchek, S., Yamazaki, T., Kurosaki, T., Bazan, J. F., Pasare, C. (2012) Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt. Proc. Natl. Acad. Sci. USA 109, 273-278.
13. Akira, S., Takeda, K. (2004) Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511.
14. Kawai, T., Akira, S. (2007) Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 13, 460-469.
15. Rossol, M., Heine, H., Meusch, U., Quandt, D., Klein, C., Sweet, M. J., Hauschildt, S. (2011) LPS-induced cytokine production in human monocytes and macrophages. Crit. Rev. Immunol. 31, 379-446.
16. Zhou, D., Huang, C., Lin, Z., Zhan, S., Kong, L., Fang, C., Li, J. (2014) Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell. Signal. 26, 192-197.
17. Newton, K., Dixit, V. M. (2012) Signaling in innate immunity and inflammation. Cold Spring Harb. Perspect. Biol. 4, 4.
18. Tsukada, J., Yoshida, Y., Kominato, Y., Auron, P. E. (2011) The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation. Cytokine 54, 6-19.
19. O’Neill, L. A., Golenbock, D., Bowie, A. G. (2013) The history of Tolllike receptors-redefining innate immunity. Nat. Rev. Immunol. 13, 453-460.
20. Guan, Y., Ranoa, D. R., Jiang, S., Mutha, S. K., Li, X., Baudry, J., Tapping, R. I. (2010) Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling. J. Immunol. 184, 5094-5103.
21. Choi, Y. J., Jung, J., Chung, H. K., Im, E., Rhee, S. H. (2013) PTEN regulates TLR5-induced intestinal inflammation by controlling Mal/TIRAP recruitment. FASEB J. 27, 243-254.
22. Choi, Y. J., Im, E., Pothoulakis, C., Rhee, S. H. (2010) TRIF modulates TLR5-dependent responses by inducing proteolytic degradation of TLR5. J. Biol. Chem. 285, 21382-21390.
23. Brandão, I., Hörmann, N., Jäckel, S., Reinhardt, C. (2015) TLR5 expression in the small intestine depends on the adaptors MyD88 and TRIF, but is independent of the enteric microbiota. Gut Microbes 6, 202-206.
24. Horng, T., Barton, G. M., Flavell, R. A., Medzhitov, R. (2002) The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420, 329-333.
25. Yamamoto, M., Sato, S., Hemmi, H., Sanjo, H., Uematsu, S., Kaisho, T., Hoshino, K., Takeuchi, O., Kobayashi, M., Fujita, T., Takeda, K., Akira, S. (2002) Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420, 324-329.
26. Hoebe, K., Janssen, E. M., Kim, S. O., Alexopoulou, L., Flavell, R. A., Han, J., Beutler, B. (2003) Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat. Immunol. 4, 1223-1229.
27. Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., Akira, S. (2003) Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301, 640-643.
28. Yamamoto, M., Sato, S., Hemmi, H., Uematsu, S., Hoshino, K., Kaisho, T., Takeuchi, O., Takeda, K., Akira, S. (2003) TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4, 1144-1150.
29. Carty, M., Goodbody, R., Schröder, M., Stack, J., Moynagh, P. N., Bowie, A. G. (2006) The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat. Immunol. 7, 1074-1081.
30. Kim, Y., Zhou, P., Qian, L., Chuang, J. Z., Lee, J., Li, C., Iadecola, C., Nathan, C., Ding, A. (2007) MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival. J. Exp. Med. 204, 2063-2074.
31. Chen, C. Y., Lin, C. W., Chang, C. Y., Jiang, S. T., Hsueh, Y. P. (2011) Sarm1, a negative regulator of innate immunity, interacts with syndecan-2 and regulates neuronal morphology. J. Cell Biol. 193, 769-784.
32. Osterloh, J. M., Yang, J., Rooney, T. M., Fox, A. N., Adalbert, R., Powell, E. H., Sheehan, A. E., Avery, M. A., Hackett, R., Logan, M. A., MacDonald, J. M., Ziegenfuss, J. S., Milde, S., Hou, Y. J., Nathan, C., Ding, A., Brown, Jr., R. H., Conforti, L., Coleman, M., Tessier-Lavigne, M., Züchner, S., Freeman, M. R. (2012) dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science 337, 481-484.
33. Mukherjee, P., Woods, T. A., Moore, R. A., Peterson, K. E. (2013) Activation of the innate signaling molecule MAVS by bunyavirus infection upregulates the adaptor protein SARM1, leading to neuronal death. Immunity 38, 705-716.
34. Gerdts, J., Summers, D. W., Sasaki, Y., DiAntonio, A., Milbrandt, J. (2013) Sarm1-mediated axon degeneration requires both SAM and TIR interactions. J. Neurosci. 33, 13569-13580.
35. Gürtler, C., Carty, M., Kearney, J., Schattgen, S. A., Ding, A., Fitzgerald, K. A., Bowie, A. G. (2014) SARM regulates CCL5 production in macrophages by promoting the recruitment of transcription factors and RNA polymerase II to the Ccl5 promoter. J. Immunol. 192, 4821-4832.
36. Gay, N. J., Symmons, M. F., Gangloff, M., Bryant, C. E. (2014) Assembly and localization of Toll-like receptor signalling complexes. Nat. Rev. Immunol. 14, 546-558.
37. Akira, S., Takeda, K., Kaisho, T. (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675-680.
38. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., Akira, S. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745.
39. Hayashi, F., Smith, K. D., Ozinsky, A., Hawn, T. R., Yi, E. C., Goodlett, D. R., Eng, J. K., Akira, S., Underhill, D. M., Aderem, A. (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103.
40. Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., Akira, S. (2002) Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3, 196-200.
41. Honda, K., Taniguchi, T. (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6, 644-658.
42. Matsumoto, M., Kikkawa, S., Kohase, M., Miyake, K., Seya, T. (2002) Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293, 1364-1369.
43. Kawai, T., Takeuchi, O., Fujita, T., Inoue, J., Mühlradt, P. F., Sato, S., Hoshino, K., Akira, S. (2001) Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167, 5887-5894.
44. Horng, T., Barton, G. M., Medzhitov, R. (2001) TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2, 835-841.
45. Fitzgerald, K. A., Palsson-McDermott, E. M., Bowie, A. G., Jefferies, C. A., Mansell, A. S., Brady, G., Brint, E., Dunne, A., Gray, P., Harte, M. T., McMurray, D., Smith, D. E., Sims, J. E., Bird, T. A., O’Neill, L. A. (2001) Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413, 78-83.
46. Toshchakov, V., Jones, B. W., Perera, P. Y., Thomas, K., Cody, M. J., Zhang, S., Williams, B. R., Major, J., Hamilton, T. A., Fenton, M. J., Vogel, S. N. (2002) TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3, 392-398.
47. Alexopoulou, L., Holt, A. C., Medzhitov, R., Flavell, R. A. (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732-738.
48. Oshiumi, H., Sasai, M., Shida, K., Fujita, T., Matsumoto, M., Seya, T. (2003) TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. J. Biol. Chem. 278, 49751-49762.
49. Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T., Seya, T. (2003) TICAM-1, an adaptor molecule that participates in Toll-like receptor 3- mediated interferon-beta induction. Nat. Immunol. 4, 161-167.
50. Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G. P., Lin, R., Hiscott, J. (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148-1151.
51. Sato, S., Sugiyama, M., Yamamoto, M., Watanabe, Y., Kawai, T., Takeda, K., Akira, S. (2003) Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 171, 4304-4310.
52. Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S. M., Maniatis, T. (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496.
53. Shimada, T., Kawai, T., Takeda, K., Matsumoto, M., Inoue, J., Tatsumi, Y., Kanamaru, A., Akira, S. (1999) IKK-i, a novel lipopolysaccharideinducible kinase that is related to IkappaB kinases. Int. Immunol. 11, 1357-1362.
54. Meylan, E., Burns, K., Hofmann, K., Blancheteau, V., Martinon, F., Kelliher, M., Tschopp, J. (2004) RIP1 is an essential mediator of Tolllike receptor 3-induced NF-kappa B activation. Nat. Immunol. 5, 503-507.
55. Kaiser, W. J., Offermann, M. K. (2005) Apoptosis induced by the Tolllike receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J. Immunol. 174, 4942-4952.
56. He, S., Liang, Y., Shao, F., Wang, X. (2011) Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc. Natl. Acad. Sci. USA 108, 20054-20059.
57. Funami, K., Sasai, M., Oshiumi, H., Seya, T., Matsumoto, M. (2008) Homo-oligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-kappaB and interferon regulatory factor-3 activation. J. Biol. Chem. 283, 18283-18291.
58. Ve, T., Williams, S. J., Kobe, B. (2015) Structure and function of Toll/interleukin-1 receptor/resistance protein (TIR) domains. Apoptosis 20, 250-261.
59. Ullah, M. O., Ve, T., Mangan, M., Alaidarous, M., Sweet, M. J., Mansell, A., Kobe, B. (2013) The TLR signalling adaptor TRIF/TICAM-1 has an N-terminal helical domain with structural similarity to IFIT proteins. Acta Crystallogr. D Biol. Crystallogr. 69, 2420-2430.
60. Tatematsu, M., Ishii, A., Oshiumi, H., Horiuchi, M., Inagaki, F., Seya, T., Matsumoto, M. (2010) A molecular mechanism for Toll-IL-1 receptor domain-containing adaptor molecule-1-mediated IRF-3 activation. J. Biol. Chem. 285, 20128-20136.
61. Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K., Akira, S. (2002) Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169, 6668-6672.
62. Hoebe, K., Du, X., Georgel, P., Janssen, E., Tabeta, K., Kim, S. O., Goode, J., Lin, P., Mann, N., Mudd, S., Crozat, K., Sovath, S., Han, J., Beutler, B. (2003) Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424, 743-748.
63. Sasai, M., Tatematsu, M., Oshiumi, H., Funami, K., Matsumoto, M., Hatakeyama, S., Seya, T. (2010) Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway. Mol. Immunol. 47, 1283-1291.
64. Fitzgerald, K. A., Rowe, D. C., Barnes, B. J., Caffrey, D. R., Visintin, A., Latz, E., Monks, B., Pitha, P. M., Golenbock, D. T. (2003) LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the Toll adapters TRAM and TRIF. J. Exp. Med. 198, 1043-1055.
65. Funami, K., Sasai, M., Ohba, Y., Oshiumi, H., Seya, T., Matsumoto, M. (2007) Spatiotemporal mobilization of Toll/IL-1 receptor domain-containing adaptor molecule-1 in response to dsRNA. J. Immunol. 179, 6867-6872.
66. Matsumoto, M., Funami, K., Tanabe, M., Oshiumi, H., Shingai, M., Seto, Y., Yamamoto, A., Seya, T. (2003) Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol. 171, 3154-3162.
67. Kagan, J. C., Su, T., Horng, T., Chow, A., Akira, S., Medzhitov, R. (2008) TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 9, 361-368.
68. Rowe, D. C., McGettrick, A. F., Latz, E., Monks, B. G., Gay, N. J., Yamamoto, M., Akira, S., O’Neill, L. A., Fitzgerald, K. A., Golenbock, D. T. (2006) The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc. Natl. Acad. Sci. USA 103, 6299-6304.
69. McGettrick, A. F., Brint, E. K., Palsson-McDermott, E. M., Rowe, D. C., Golenbock, D. T., Gay, N. J., Fitzgerald, K. A., O’Neill, L. A. (2006) Trif-related adapter molecule is phosphorylated by PKCepsilon during Tolllike receptor 4 signaling. Proc. Natl. Acad. Sci. USA 103, 9196-9201.
70. Shalova, I. N., Kajiji, T., Lim, J. Y., Gómez-Piña, V., Fernández-Ruíz, I., Arnalich, F., Iau, P. T., López-Collazo, E., Wong, S. C., Biswas, S. K. (2012) CD16 regulates TRIF-dependent TLR4 response in human monocytes and their subsets. J. Immunol. 188, 3584-3593.
71. Lee, H. K., Dunzendorfer, S., Soldau, K., Tobias, P. S. (2006) Doublestranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 24, 153-163.
72. Di Gioia, M., Zanoni, I. (2015) Toll-like receptor co-receptors as master regulators of the immune response. Mol. Immunol. 63, 143-152.
73. Zanoni, I., Granucci, F. (2013) Role of CD14 in host protection against infections and in metabolism regulation. Front. Cell. Infect. Microbiol. 3, 32.
74. Manukyan, M., Triantafilou, K., Triantafilou, M., Mackie, A., Nilsen, N., Espevik, T., Wiesmüller, K. H., Ulmer, A. J., Heine, H. (2005) Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1. Eur. J. Immunol. 35, 911-921.
75. Nakata, T., Yasuda, M., Fujita, M., Kataoka, H., Kiura, K., Sano, H., Shibata, K. (2006) CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Cell. Microbiol. 8, 1899-1909.
76. Rapsinski, G. J., Newman, T. N., Oppong, G. O., van Putten, J. P., Tükel, Ç. (2013) CD14 protein acts as an adaptor molecule for the immune recognition of Salmonella curli fibers. J. Biol. Chem. 288, 14178-14188.
77. Triantafilou, M., Gamper, F. G., Haston, R. M., Mouratis, M. A., Morath, S., Hartung, T., Triantafilou, K. (2006) Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J. Biol. Chem. 281, 31002-31011.
78. Hoebe, K., Georgel, P., Rutschmann, S., Du, X., Mudd, S., Crozat, K., Sovath, S., Shamel, L., Hartung, T., Zähringer, U., Beutler, B. (2005) CD36 is a sensor of diacylglycerides. Nature 433, 523-527.
79. Baumann, C. L., Aspalter, I. M., Sharif, O., Pichlmair, A., Blüml, S., Grebien, F., Bruckner, M., Pasierbek, P., Aumayr, K., Planyavsky, M., Bennett, K. L., Colinge, J., Knapp, S., Superti-Furga, G. (2010) CD14 is a coreceptor of Toll-like receptors 7 and 9. J. Exp. Med. 207, 2689-2701.
80. Weber, C., Müller, C., Podszuweit, A., Montino, C., Vollmer, J., Forsbach, A. (2012) Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects). Immunology 136, 64-77.
81. Carpenter, S., Carlson, T., Dellacasagrande, J., Garcia, A., Gibbons, S., Hertzog, P., Lyons, A., Lin, L. L., Lynch, M., Monie, T., Murphy, C., Seidl, K. J., Wells, C., Dunne, A., O’Neill, L. A. (2009) TRIL, a functional component of the TLR4 signaling complex, highly expressed in brain. J. Immunol. 183, 3989-3995.
82. Carpenter, S., Wochal, P., Dunne, A., O’Neill, L. A. (2011) Toll-like receptor 3 (TLR3) signaling requires TLR4 Interactor with leucine-rich REPeats (TRIL). J. Biol. Chem. 286, 38795-38804.
83. Tabeta, K., Hoebe, K., Janssen, E. M., Du, X., Georgel, P., Crozat, K., Mudd, S., Mann, N., Sovath, S., Goode, J., Shamel, L., Herskovits, A. A., Portnoy, D. A., Cooke, M., Tarantino, L. M., Wiltshire, T., Steinberg, B. E., Grinstein, S., Beutler, B. (2006) The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 7, 156-164.
84. Akashi-Takamura, S., Miyake, K. (2008) TLR accessory molecules. Curr. Opin. Immunol. 20, 420-425.
85. Eigenbrod, T., Franchi, L., Muñoz-Planillo, R., Kirschning, C. J., Freudenberg, M. A., Núñez, G., Dalpke, A. (2012) Bacterial RNA mediates activation of caspase-1 and IL-1b release independently of TLRs 3, 7, 9 and TRIF but is dependent on UNC93B. J. Immunol. 189, 328-336.
86. Schamber-Reis, B. L., Petritus, P. M., Caetano, B. C., Martinez, E. R., Okuda, K., Golenbock, D., Scott, P., Gazzinelli, R. T. (2013) UNC93B1 and nucleic acid-sensing Toll-like receptors mediate host resistance to infection with Leishmania major. J. Biol. Chem. 288, 7127-7136.
87. Pohar, J., Pirher, N., Benčina, M., Manček-Keber, M., Jerala, R. (2013) The role of UNC93B1 protein in surface localization of TLR3 receptor and in cell priming to nucleic acid agonists. J. Biol. Chem. 288, 442-454.
88. Shen, Y., Li, N. L., Wang, J., Liu, B., Lester, S., Li, K. (2012) TRIM56 is an essential component of the TLR3 antiviral signaling pathway. J. Biol. Chem. 287, 36404-36413.
89. Tsuchida, T., Zou, J., Saitoh, T., Kumar, H., Abe, T., Matsuura, Y., Kawai, T., Akira, S. (2010) The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 33, 765-776.
90. Uchil, P. D., Hinz, A., Siegel, S., Coenen-Stass, A., Pertel, T., Luban, J., Mothes, W. (2013) TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. J. Virol. 87, 257-272.
91. Murphy, M., Xiong, Y., Pattabiraman, G., Qiu, F., Medvedev, A. E. (2015) Pellino-1 positively regulates Toll-like receptor (TLR) 2 and TLR4 signaling and Is suppressed upon induction of endotoxin tolerance. J. Biol. Chem. 290, 19218-19232.
92. Velasco, G., Grkovic, S., Ansieau, S. (2006) New insights into BS69 functions. J. Biol. Chem. 281, 16546-16550.
93. Guo, R., Zheng, L., Park, J. W., Lv, R., Chen, H., Jiao, F., Xu, W., Mu, S., Wen, H., Qiu, J., Wang, Z., Yang, P., Wu, F., Hui, J., Fu, X., Shi, X., Shi, Y. G., Xing, Y., Lan, F., Shi, Y. (2014) BS69/ZMYND11 reads and connects histone H3.3 lysine 36 trimethylation-decorated chromatin to regulated pre-mRNA processing. Mol. Cell 56, 298-310.
94. Wang, J., Qin, S., Li, F., Li, S., Zhang, W., Peng, J., Zhang, Z., Gong, Q., Wu, J., Shi, Y. (2014) Crystal structure of human BS69 Bromo-ZnF-PWWP reveals its role in H3K36me3 nucleosome binding. Cell Res. 24, 890-893.
95. Takaki, H., Oshiumi, H., Sasai, M., Kawanishi, T., Matsumoto, M., Seya, T. (2009) Oligomerized TICAM-1 (TRIF) in the cytoplasm recruits nuclear BS69 to enhance NF-kappaB activation and type I IFN induction. Eur. J. Immunol. 39, 3469-3476.
96. Ikeda, O., Miyasaka, Y., Yoshida, R., Mizushima, A., Oritani, K., Sekine, Y., Kuroda, M., Yasui, T., Fujimuro, M., Muromoto, R., Nanbo, A., Matsuda, T. (2010) BS69 cooperates with TRAF3 in the regulation of Epstein-Barr virus-derived LMP1/CTAR1-induced NF-kappaB activation. FEBS Lett. 584, 865-872.
97. Gaczynska, M., Rock, K. L., Spies, T., Goldberg, A. L. (1994) Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc. Natl. Acad. Sci. USA 91, 9213-9217.
98. Groettrup, M., Khan, S., Schwarz, K., Schmidtke, G. (2001) Interferongamma inducible exchanges of 20S proteasome active site subunits: why? Biochimie 83, 367-372.
99. Reis, J., Hassan, F., Guan, X. Q., Shen, J., Monaco, J. J., Papasian, C. J., Qureshi, A. A., Van Way III, C. W., Vogel, S. N., Morrison, D. C., Qureshi, N. (2011) The immunoproteasomes regulate LPS-induced TRIF/TRAM signaling pathway in murine macrophages. Cell Biochem. Biophys. 60, 119-126.
100. Sgarbanti, M., Marsili, G., Remoli, A. L., Orsatti, R., Battistini, A. (2007) IRF-7: new role in the regulation of genes involved in adaptive immunity. Ann. N. Y. Acad. Sci. 1095, 325-333.
101. Hu, Y. H., Zhang, Y., Jiang, L. Q., Wang, S., Lei, C. Q., Sun, M. S., Shu, H. B., Liu, Y. (2015) WDFY1 mediates TLR3/4 signaling by recruiting TRIF. EMBO Rep. 16, 447-455.
102. Anantharaman, V., Aravind, L. (2002) The GOLD domain, a novel protein module involved in Golgi function and secretion. Genome Biol. 3, research0023.
103. Palsson-McDermott, E. M., Doyle, S. L., McGettrick, A. F., Hardy, M., Husebye, H., Banahan, K., Gong, M., Golenbock, D., Espevik, T., O’Neill, L. A. (2009) TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway. Nat. Immunol. 10, 579-586.
104. Doyle, S. L., Husebye, H., Connolly, D. J., Espevik, T., O’Neill, L. A., McGettrick, A. F. (2012) The GOLD domain-containing protein TMED7 inhibits TLR4 signalling from the endosome upon LPS stimulation. Nat. Commun. 3, 707.
105. Suzuki, M., Pritchard, D. K., Becker, L., Hoofnagle, A. N., Tanimura, N., Bammler, T. K., Beyer, R. P., Bumgarner, R., Vaisar, T., de Beer, M. C., de Beer, F. C., Miyake, K., Oram, J. F., Heinecke, J. W. (2010) Highdensity lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide. Circulation 122, 1919-1927.
106. Xue, Q., Zhou, Z., Lei, X., Liu, X., He, B., Wang, J., Hung, T. (2012) TRIM38 negatively regulates TLR3-mediated IFN-b signaling by targeting TRIF for degradation. PLoS One 7, e46825.
107. Kayagaki, N., Phung, Q., Chan, S., Chaudhari, R., Quan, C., O’Rourke, K. M., Eby, M., Pietras, E., Cheng, G., Bazan, J. F., Zhang, Z., Arnott, D., Dixit, V. M. (2007) DUBA: a deubiquitinase that regulates type I interferon production. Science 318, 1628-1632.
108. Frobøse, H., Rønn, S. G., Heding, P. E., Mendoza, H., Cohen, P., Mandrup-Poulsen, T., Billestrup, N. (2006) Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol. Endocrinol. 20, 1587-1596.
109. Yu, Y., Hayward, G. S. (2010) The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3. Immunity 33, 863-877.
110. Saitoh, T., Tun-Kyi, A., Ryo, A., Yamamoto, M., Finn, G., Fujita, T., Akira, S., Yamamoto, N., Lu, K. P., Yamaoka, S. (2006) Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat. Immunol. 7, 598-605.
111. Shuai, K., Liu, B. (2005) Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol. 5, 593-605.
112. Shuai, K. (2006) Regulation of cytokine signaling pathways by PIAS proteins. Cell Res. 16, 196-202.
113. Rytinki, M. M., Kaikkonen, S., Pehkonen, P., Jääskeläinen, T., Palvimo, J. J. (2009) PIAS proteins: pleiotropic interactors associated with SUMO. Cell. Mol. Life Sci. 66, 3029-3041.
114. Liu, B., Liao, J., Rao, X., Kushner, S. A., Chung, C. D., Chang, D. D., Shuai, K. (1998) Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 95, 10626-10631.
115. Zhang, J., Xu, L. G., Han, K. J., Wei, X., Shu, H. B. (2004) PIASy represses TRIF-induced ISRE and NF-kappaB activation but not apoptosis. FEBS Lett. 570, 97-101.
116. Xiong, R., Nie, L., Xiang, L. X., Shao, J. Z. (2012) Characterization of a PIAS4 homologue from zebrafish: insights into its conserved negative regulatory mechanism in the TRIF, MAVS, and IFN signaling pathways during vertebrate evolution. J. Immunol. 188, 2653-2668.
117. Jang, H. D., Yoon, K., Shin, Y. J., Kim, J., Lee, S. Y. (2004) PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit. J. Biol. Chem. 279, 24873-24880.
118. Liu, Y., Bridges, R., Wortham, A., Kulesz-Martin, M. (2012) NF-kB repression by PIAS3 mediated RelA SUMOylation. PLoS One 7, e37636.
119. Liu, B., Yang, R., Wong, K. A., Getman, C., Stein, N., Teitell, M. A., Cheng, G., Wu, H., Shuai, K. (2005) Negative regulation of NF-kappaB signaling by PIAS1. Mol. Cell. Biol. 25, 1113-1123.
120. Jabir, M. S., Ritchie, N. D., Li, D., Bayes, H. K., Tourlomousis, P., Puleston, D., Lupton, A., Hopkins, L., Simon, A. K., Bryant, C., Evans, T. J. (2014) Caspase-1 cleavage of the TLR adaptor TRIF inhibits autophagy and b-interferon production during Pseudomonas aeruginosa infection. Cell Host Microbe 15, 214-227.
121. Inomata, M., Niida, S., Shibata, K., Into, T. (2012) Regulation of Tolllike receptor signaling by NDP52-mediated selective autophagy is normally inactivated by A20. Cell. Mol. Life Sci. 69, 963-979.
122. Biswas, N., Liu, S., Ronni, T., Aussenberg, S. E., Liu, W., Fujita, T., Wang, T. (2011) The ubiquitin-like protein PLIC-1 or ubiquilin 1 inhibits TLR3-Trif signaling. PLoS One 6, e21153.
123. Lee, S. M., Kim, E. J., Suk, K., Lee, W. H. (2011) CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1. J. Immunol. 186, 6296-6303.
124. Kim, E. J., Lee, S. M., Suk, K., Lee, W. H. (2012) CD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell lines. Immunology 135, 226-235.
125. Lee, S. M., Suk, K., Lee, W. H. (2012) Synthetic peptides containing ITIM-like sequences of IREM-1 (CD300F) differentially regulate MyD88 and TRIF-mediated TLR signalling through activation of SHP and/or PI3K. Clin. Exp. Immunol. 167, 438-446.
126. An, H., Zhao, W., Hou, J., Zhang, Y., Xie, Y., Zheng, Y., Xu, H., Qian, C., Zhou, J., Yu, Y., Liu, S., Feng, G., Cao, X. (2006) SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. Immunity 25, 919-928.
127. Qu, L., Feng, Z., Yamane, D., Liang, Y., Lanford, R. E., Li, K., Lemon, S. M. (2011) Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathog. 7, e1002169.
128. Lei, X., Sun, Z., Liu, X., Jin, Q., He, B., Wang, J. (2011) Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 85, 8811-8818.
129. Mukherjee, A., Morosky, S. A., Delorme-Axford, E., Dybdahl-Sissoko, N., Oberste, M. S., Wang, T., Coyne, C. B. (2011) The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 7, e1001311.
130. Li, X. D., Sun, L., Seth, R. B., Pineda, G., Chen, Z. J. (2005) Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad. Sci. USA 102, 17717-17722.
131. Stack, J., Haga, I. R., Schröder, M., Bartlett, N. W., Maloney, G., Reading, P. C., Fitzgerald, K. A., Smith, G. L., Bowie, A. G. (2005) Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med. 201, 1007-1018.
132. Oda, S., Franklin, E., Khan, A. R. (2011) Poxvirus A46 protein binds to TIR domain-containing Mal/TIRAP via an a-helical sub-domain. Mol. Immunol. 48, 2144-2150.
133. Harte, M. T., Haga, I. R., Maloney, G., Gray, P., Reading, P. C., Bartlett, N. W., Smith, G. L., Bowie, A., O’Neill, L. A. (2003) The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197, 343-351.
134. Lang, T., Lo, C., Skinner, N., Locarnini, S., Visvanathan, K., Mansell, A. (2011) The hepatitis B e antigen (HBeAg) targets and suppresses activation of the Toll-like receptor signaling pathway. J. Hepatol. 55, 762-769.
135. Okumura, A., Alce, T., Lubyova, B., Ezelle, H., Strebel, K., Pitha, P. M. (2008) HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 373, 85-97.
136. Newman, R. M., Salunkhe, P., Godzik, A., Reed, J. C. (2006) Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll/interleukin-1 receptor family proteins. Infect. Immun. 74, 594-601.
137. Cirl, C., Wieser, A., Yadav, M., Duerr, S., Schubert, S., Fischer, H., Stappert, D., Wantia, N., Rodriguez, N., Wagner, H., Svanborg, C., Miethke, T. (2008) Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat. Med. 14, 399-406.
138. Yadav, M., Zhang, J., Fischer, H., Huang, W., Lutay, N., Cirl, C., Lum, J., Miethke, T., Svanborg, C. (2010) Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence. PLoS Pathog. 6, e1001120.
139. Alaidarous, M., Ve, T., Casey, L. W., Valkov, E., Ericsson, D. J., Ullah, M. O., Schembri, M. A., Mansell, A., Sweet, M. J., Kobe, B. (2014) Mechanism of bacterial interference with TLR4 signaling by Brucella Toll/interleukin-1 receptor domain-containing protein TcpB. J. Biol. Chem. 289, 654-668.
140. Zhang, Q., Zmasek, C. M., Cai, X., Godzik, A. (2011) TIR domain-containing adaptor SARM is a late addition to the ongoing microbe-host dialog. Dev. Comp. Immunol. 35, 461-468.
141. Han, K. J., Su, X., Xu, L. G., Bin, L. H., Zhang, J., Shu, H. B. (2004) Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways. J. Biol. Chem. 279, 15652-15661.
142. Kaiser, W. J., Sridharan, H., Huang, C., Mandal, P., Upton, J. W., Gough, P. J., Sehon, C. A., Marquis, R. W., Bertin, J., Mocarski, E. S. (2013) Tolllike receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J. Biol. Chem. 288, 31268-31279.
143. Hyun, J., Kanagavelu, S., Fukata, M. (2013) A unique host defense pathway: TRIF mediates both antiviral and antibacterial immune responses. Microbes Infect. 15, 1-10.
144. Perales-Linares, R., Navas-Martin, S. (2013) Toll-like receptor 3 in viral pathogenesis: friend or foe? Immunology 140, 153-167.
145. Wang, T., Town, T., Alexopoulou, L., Anderson, J. F., Fikrig, E., Flavell, R. A. (2004) Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10, 1366-1373.
146. Daffis, S., Samuel, M. A., Suthar, M. S., Gale, Jr., M., Diamond, M. S. (2008) Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 82, 10349-10358.
147. Blázquez, A. B., Sáiz, J. C. (2010) West Nile virus (WNV) transmission routes in the murine model: intrauterine, by breastfeeding and after cannibal ingestion. Virus Res. 151, 240-243.
148. Guo, Y., Audry, M., Ciancanelli, M., Alsina, L., Azevedo, J., Herman, M., Anguiano, E., Sancho-Shimizu, V., Lorenzo, L., Pauwels, E., Philippe, P. B., Pérez de Diego, R., Cardon, A., Vogt, G., Picard, C., Andrianirina, Z. Z., Rozenberg, F., Lebon, P., Plancoulaine, S., Tardieu, M., Valérie Doireau, Jouanguy, E., Chaussabel, D., Geissmann, F., Abel, L., Casanova, J. L., Zhang, S. Y. (2011) Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J. Exp. Med. 208, 2083-2098.
149. Lafaille, F. G., Pessach, I. M., Zhang, S. Y., Ciancanelli, M. J., Herman, M., Abhyankar, A., Ying, S. W., Keros, S., Goldstein, P. A., Mostoslavsky, G., Ordovas-Montanes, J., Jouanguy, E., Plancoulaine, S., Tu, E., Elkabetz, Y., Al-Muhsen, S., Tardieu, M., Schlaeger, T. M., Daley, G. Q., Abel, L., Casanova, J. L., Studer, L., Notarangelo, L. D. (2012) Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 491, 769-773.
150. Sancho-Shimizu, V., Pérez de Diego, R., Lorenzo, L., Halwani, R., Alangari, A., Israelsson, E., Fabrega, S., Cardon, A., Maluenda, J., Tatematsu, M., Mahvelati, F., Herman, M., Ciancanelli, M., Guo, Y., AlSum, Z., Alkhamis, N., Al-Makadma, A. S., Ghadiri, A., Boucherit, S., Plancoulaine, S., Picard, C., Rozenberg, F., Tardieu, M., Lebon, P., Jouanguy, E., Rezaei, N., Seya, T., Matsumoto, M., Chaussabel, D., Puel, A., Zhang, S. Y., Abel, L., Al-Muhsen, S., Casanova, J. L. (2011) Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J. Clin. Invest. 121, 4889-4902.
151. Hidaka, F., Matsuo, S., Muta, T., Takeshige, K., Mizukami, T., Nunoi, H. (2006) A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy. Clin. Immunol. 119, 188-194.
152. Tyler, K. L. (2004) Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret’s. Herpes 11 (Suppl 2), 57A-64A.
153. Reinert, L. S., Harder, L., Holm, C. K., Iversen, M. B., Horan, K. A., Dagnæs-Hansen, F., Ulhøi, B. P., Holm, T. H., Mogensen, T. H., Owens, T., Nyengaard, J. R., Thomsen, A. R., Paludan, S. R. (2012) TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J. Clin. Invest. 122, 1368-1376.
154. Wollish, A. C., Ferris, M. T., Blevins, L. K., Loo, Y. M., Gale, Jr., M., Heise, M. T. (2013) An attenuating mutation in a neurovirulent Sindbis virus strain interacts with the IPS-1 signaling pathway in vivo. Virology 435, 269-280.
155. Oshiumi, H., Okamoto, M., Fujii, K., Kawanishi, T., Matsumoto, M., Koike, S., Seya, T. (2011) The TLR3/TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection. J. Immunol. 187, 5320-5327.
156. Esposito, S., Molteni, C. G., Giliani, S., Mazza, C., Scala, A., Tagliaferri, L., Pelucchi, C., Fossali, E., Plebani, A., Principi, N. (2012) Toll-like receptor 3 gene polymorphisms and severity of pandemic A/H1N1/2009 influenza in otherwise healthy children. Virol. J. 9, 270.
157. Guillot, L., Le Goffic, R., Bloch, S., Escriou, N., Akira, S., Chignard, M., Si-Tahar, M. (2005) Involvement of Toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280, 5571-5580.
158. Haller, O., Staeheli, P., Kochs, G. (2009) Protective role of interferon-induced Mx GTPases against influenza viruses. Rev. - Off. Int. Epizoot. 28, 219-231.
159. Le Goffic, R., Balloy, V., Lagranderie, M., Alexopoulou, L., Escriou, N., Flavell, R., Chignard, M., Si-Tahar, M. (2006) Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2, e53.
160. Hutchens, M., Luker, K. E., Sottile, P., Sonstein, J., Lukacs, N. W., Núñez, G., Curtis, J. L., Luker, G. D. (2008) TLR3 increases disease morbidity and mortality from vaccinia infection. J. Immunol. 180, 483-491.
161. Aeffner, F., Traylor, Z. P., Yu, E. N., Davis, I. C. (2011) Double-stranded RNA induces similar pulmonary dysfunction to respiratory syncytial virus in BALB/c mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 301, L99-L109.
162. Hardarson, H. S., Baker, J. S., Yang, Z., Purevjav, E., Huang, C. H., Alexopoulou, L., Li, N., Flavell, R. A., Bowles, N. E., Vallejo, J. G. (2007) Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. Am. J. Physiol. Heart Circ. Physiol. 292, H251-H258.
163. Richer, M. J., Lavallée, D. J., Shanina, I., Horwitz, M. S. (2009) Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS One 4, e4127.
164. Gowen, B. B., Hoopes, J. D., Wong, M. H., Jung, K. H., Isakson, K. C., Alexopoulou, L., Flavell, R. A., Sidwell, R. W. (2006) TLR3 deletion limits mortality and disease severity due to Phlebovirus infection. J. Immunol. 177, 6301-6307.
165. Li, K., Li, N. L., Wei, D., Pfeffer, S. R., Fan, M., Pfeffer, L. M. (2012) Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates. Hepatology 55, 666-675.
166. Wang, N., Liang, Y., Devaraj, S., Wang, J., Lemon, S. M., Li, K. (2009) Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells. J. Virol. 83, 9824-9834.
167. Rong, Y., Song, H., You, S., Zhu, B., Zang, H., Zhao, Y., Li, Y., Wan, Z., Liu, H., Zhang, A., Xiao, L., Xin, S. (2013) Association of Toll-like receptor 3 polymorphisms with chronic hepatitis B and hepatitis B-related acute-on-chronic liver failure. Inflammation 36, 413-418.
168. Li, G., Zheng, Z. (2013) Toll-like receptor 3 genetic variants and susceptibility to hepatocellular carcinoma and HBV-related hepatocellular carcinoma. Tumour Biol. 34, 1589-1594.
169. Bartosch, B., Thimme, R., Blum, H. E., Zoulim, F. (2009) Hepatitis C virus-induced hepatocarcinogenesis. J. Hepatol. 51, 810-820.
170. Al-Qahtani, A., Al-Ahdal, M., Abdo, A., Sanai, F., Al-Anazi, M., Khalaf, N., Viswan, N. A., Al-Ashgar, H., Al-Humaidan, H., Al-Suwayeh, R., Hussain, Z., Alarifi, S., Al-Okail, M., Almajhdi, F. N. (2012) Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients. J. Med. Virol. 84, 1353-1359.
171. Ayoobi, F., Hassanshahi, G., Zainodini, N., Khorramdelazad, H., Arababadi, M. K., Kennedy, D. (2013) Reduced expression of TRIF in chronic HBV infected Iranian patients. Clin. Res. Hepatol. Gastroenterol. 37, 491-495.
172. Huang, Y. W., Lin, S. C., Wei, S. C., Hu, J. T., Chang, H. Y., Huang, S. H., Chen, D. S., Chen, P. J., Hsu, P. N., Yang, S. S., Kao, J. H. (2013) Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy. Antivir. Ther. (Lond.) 18, 877-884.
173. Wang, K., Liu, H., He, Y., Chen, T., Yang, Y., Niu, Y., Chen, H., Chen, Y., Liu, J., Ye, F., Lin, S., Zhao, Y. (2010) Correlation of TLR1-10 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure. Hum. Immunol. 71, 950-956.
174. Heiberg, I. L., Winther, T. N., Paludan, S. R., Hogh, B. (2012) Pattern recognition receptor responses in children with chronic hepatitis B virus infection. J. Clin. Virol. 54, 229-234.
175. McCartney, S. A., Vermi, W., Lonardi, S., Rossini, C., Otero, K., Calderon, B., Gilfillan, S., Diamond, M. S., Unanue, E. R., Colonna, M. (2011) RNA sensor-induced type I IFN prevents diabetes caused by a b cell-tropic virus in mice. J. Clin. Invest. 121, 1497-1507.
176. Negishi, H., Osawa, T., Ogami, K., Ouyang, X., Sakaguchi, S., Koshiba, R., Yanai, H., Seko, Y., Shitara, H., Bishop, K., Yonekawa, H., Tamura, T., Kaisho, T., Taya, C., Taniguchi, T., Honda, K. (2008) A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc. Natl. Acad. Sci. USA 105, 20446-20451.
177. Abston, E. D., Coronado, M. J., Bucek, A., Bedja, D., Shin, J., Kim, J. B., Kim, E., Gabrielson, K. L., Georgakopoulos, D., Mitzner, W., Fairweather, D. (2012) Th2 regulation of viral myocarditis in mice: different roles for TLR3 versus TRIF in progression to chronic disease. Clin. Dev. Immunol. 2012, 129486.
178. Riad, A., Westermann, D., Zietsch, C., Savvatis, K., Becher, P. M., Bereswill, S., Heimesaat, M. M., Lettau, O., Lassner, D., Dörner, A., Poller, W., Busch, M., Felix, S. B., Schultheiss, H. P., Tschöpe, C. (2011) TRIF is a critical survival factor in viral cardiomyopathy. J. Immunol. 186, 2561-2570.
179. Cuenca, A. G., Joiner, D. N., Gentile, L. F., Cuenca, A. L., Wynn, J. L., Kelly-Scumpia, K. M., Scumpia, P. O., Behrns, K. E., Efron, P. A., Nacionales, D., Lui, C., Wallet, S. M., Reeves, W. H., Mathews, C. E., Moldawer, L. L. (2015) TRIF-dependent innate immune activation is critical for survival to neonatal gram-negative sepsis. J. Immunol. 194, 1169-1177.
180. Tuberculosis Research Unit. (2015) Polymorphisms in TICAM2 and IL1B are associated with TB. Genes Immun. 16, 127-133.
181. Kim, T. H., Shin, S. J., Park, Y. M., Jung, I. D., Ryu, S. W., Kim, D. J., Park, J. H., Park, J. H. (2015) Critical role of TRIF and MyD88 in Mycobacterium tuberculosis Hsp70-mediated activation of dendritic cells. Cytokine 71, 139-144.
182. Cai, S., Batra, S., Shen, L., Wakamatsu, N., Jeyaseelan, S. (2009) Both TRIF- and MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection. J. Immunol. 183, 6629-6638.
183. Power, M. R., Li, B., Yamamoto, M., Akira, S., Lin, T. J. (2007) A role of Toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta in the host response to Pseudomonas aeruginosa lung infection in mice. J. Immunol. 178, 3170-3176.
184. Jeyaseelan, S., Young, S. K., Fessler, M. B., Liu, Y., Malcolm, K. C., Yamamoto, M., Akira, S., Worthen, G. S. (2007) Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling contributes to innate immune responses in the lung during Escherichia coli pneumonia. J. Immunol. 178, 3153-3160.
185. Bereswill, S., Fischer, A., Plickert, R., Haag, L. M., Otto, B., Kühl, A. A., Dasti, J. I., Zautner, A. E., Muñoz, M., Loddenkemper, C., Gross, U., Göbel, U. B., Heimesaat, M. M. (2011) Novel murine infection models provide deep insights into the “ménage à trois” of Campylobacter jejuni, microbiota and host innate immunity. PLoS One 6, e20953.
186. Stockinger, S., Duerr, C. U., Fulde, M., Dolowschiak, T., Pott, J., Yang, I., Eibach, D., Bäckhed, F., Akira, S., Suerbaum, S., Brugman, M., Hornef, M. W. (2014) TRIF signaling drives homeostatic intestinal epithelial antimicrobial peptide expression. J. Immunol. 193, 4223-4234.
187. Gurung, P., Malireddi, R. K., Anand, P. K., Demon, D., Vande Walle, L., Liu, Z., Vogel, P., Lamkanfi, M., Kanneganti, T. D. (2012) Toll or interleukin-1 receptor (TIR) domain-containing adaptor inducing interferon-b (TRIF)-mediated caspase-11 protease production integrates Toll-like receptor 4 (TLR4) protein- and Nlrp3 inflammasome-mediated host defense against enteropathogens. J. Biol. Chem. 287, 34474-34483.
188. Broz, P., Ruby, T., Belhocine, K., Bouley, D. M., Kayagaki, N., Dixit, V. M., Monack, D. M. (2012) Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 490, 288-291.
189. Rathinam, V. A., Vanaja, S. K., Waggoner, L., Sokolovska, A., Becker, C., Stuart, L. M., Leong, J. M., Fitzgerald, K. A. (2012) TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gramnegative bacteria. Cell 150, 606-619.
190. Sotolongo, J., Kanagavelu, S., Hyun, J., Ruiz, J., Fukata, M. (2012) TRIF mobilizes unique primary defense against Gram-negative bacteria in intestinal interface. Gut Microbes 3, 437-441.
191. Talbot, S., Tötemeyer, S., Yamamoto, M., Akira, S., Hughes, K., Gray, D., Barr, T., Mastroeni, P., Maskell, D. J., Bryant, C. E. (2009) Toll-like receptor 4 signalling through MyD88 is essential to control Salmonella enterica serovar Typhimurium infection, but not for the initiation of bacterial clearance. Immunology 128, 472-483.
192. Hagar, J. A., Powell, D. A., Aachoui, Y., Ernst, R. K., Miao, E. A. (2013) Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 341, 1250-1253.
193. Bugl, S., Wirths, S., Radsak, M. P., Schild, H., Stein, P., André, M. C., Müller, M. R., Malenke, E., Wiesner, T., Märklin, M., Frick, J. S., Handgretinger, R., Rammensee, H. G., Kanz, L., Kopp, H. G. (2013) Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling. Blood 121, 723-733.
194. Kanagavelu, S., Flores, C., Termini, J. M., Riveron, R., Romero, L., Chung, K., Ruiz, J., Hyun, J., Yuan, X., Dagvadorj, J., Fukata, M. (2015) TIR-domain-containing adapter-inducing interferon-b (TRIF) regulates Th17-mediated intestinal immunopathology in colitis. Mucosal Immunol. 8, 296-306.
195. Saitoh, T., Fujita, N., Jang, M. H., Uematsu, S., Yang, B. G., Satoh, T., Omori, H., Noda, T., Yamamoto, N., Komatsu, M., Tanaka, K., Kawai, T., Tsujimura, T., Takeuchi, O., Yoshimori, T., Akira, S. (2008) Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456, 264-268.
196. Rahman, F. Z., Smith, A. M., Hayee, B., Marks, D. J., Bloom, S. L., Segal, A. W. (2010) Delayed resolution of acute inflammation in ulcerative colitis is associated with elevated cytokine release downstream of TLR4. PLoS One 5, e9891.
197. Cole, J. E., Navin, T. J., Cross, A. J., Goddard, M. E., Alexopoulou, L., Mitra, A. T., Davies, A. H., Flavell, R. A., Feldmann, M., Monaco, C. (2011) Unexpected protective role for Toll-like receptor 3 in the arterial wall. Proc. Natl. Acad. Sci. USA 108, 2372-2377.
198. Richards, M. R., Black, A. S., Bonnet, D. J., Barish, G. D., Woo, C. W., Tabas, I., Curtiss, L. K., Tobias, P. S. (2013) The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice. Innate Immun. 19, 20-29.
199. Lundberg, A. M., Ketelhuth, D. F., Johansson, M. E., Gerdes, N., Liu, S., Yamamoto, M., Akira, S., Hansson, G. K. (2013) Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis. Cardiovasc. Res. 99, 364-373.
200. Abdollahi-Roodsaz, S., van de Loo, F. A., Koenders, M. I., Helsen, M. M., Walgreen, B., van den Bersselaar, L. A., Arntz, O. J., Takahashi, N., Joosten, L. A., van den Berg, W. B. (2012) Destructive role of myeloid differentiation factor 88 and protective role of TRIF in interleukin-17-dependent arthritis in mice. Arthritis Rheum. 64, 1838-1847.
201. Yarilina, A., DiCarlo, E., Ivashkiv, L. B. (2007) Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. J. Immunol. 178, 2204-2211.
202. Sachdev, U., Cui, X., McEnaney, R., Wang, T., Benabou, K., Tzeng, E. (2012) TLR2 and TLR4 mediate differential responses to limb ischemia through MyD88-dependent and independent pathways. PLoS One 7, e50654.
203. Hosmane, S., Tegenge, M. A., Rajbhandari, L., Uapinyoying, P., Kumar, N. G., Thakor, N., Venkatesan, A. (2012) Toll/interleukin-1 receptor domain-containing adapter inducing interferon-b mediates microglial phagocytosis of degenerating axons. J. Neurosci. 32, 7745-7757.
204. Lin, Q., Fang, D., Fang, J., Ren, X., Yang, X., Wen, F., Su, S. B. (2011) Impaired wound healing with defective expression of chemokines and recruitment of myeloid cells in TLR3-deficient mice. J. Immunol. 186, 3710-3717.
205. Borkowski, A. W., Kuo, I. H., Bernard, J. J., Yoshida, T., Williams, M. R., Hung, N. J., Yu, B. D., Beck, L. A., Gallo, R. L. (2015) Toll-like receptor 3 activation is required for normal skin barrier repair following UV damage. J. Invest. Dermatol. 135, 569-578.
206. Palchetti, S., Starace, D., De Cesaris, P., Filippini, A., Ziparo, E., Riccioli, A. (2015) Transfected poly(I:C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells. J. Biol. Chem. 290, 5470-5483.
207. Mata-Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., Mitchell, T. C. (2007) The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316, 1628-1632.
208. Kolb, J. P., Casella, C. R., SenGupta, S., Chilton, P. M., Mitchell, T. C. (2014) Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF. Sci. Signal. 7, ra108.
209. Tanimura, N., Saitoh, S., Ohto, U., Akashi-Takamura, S., Fujimoto, Y., Fukase, K., Shimizu, T., Miyake, K. (2014) The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4/MD2 complex at the plasma membrane. Int. Immunol. 26, 307-314.
210. Gearing, A. J. (2007) Targeting Toll-like receptors for drug development: a summary of commercial approaches. Immunol. Cell Biol. 85, 490-494.
211. Cheng, K., Wang, X., Yin, H. (2011) Small-molecule inhibitors of the TLR3/dsRNA complex. J. Am. Chem. Soc. 133, 3764-3767.
212. Lysakova-Devine, T., Keogh, B., Harrington, B., Nagpal, K., Halle, A., Golenbock, D. T., Monie, T., Bowie, A. G. (2010) Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule. J. Immunol. 185, 4261-4271.
213. Kanzler, H., Barrat, F. J., Hessel, E. M., Coffman, R. L. (2007) Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat. Med. 13, 552-559.
214. Zaks, K., Jordan, M., Guth, A., Sellins, K., Kedl, R., Izzo, A., Bosio, C., Dow, S. (2006) Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes. J. Immunol. 176, 7335-7345.
215. Ichinohe, T., Kawaguchi, A., Tamura, S., Takahashi, H., Sawa, H., Ninomiya, A., Imai, M., Itamura, S., Odagiri, T., Tashiro, M., Chiba, J., Sata, T., Kurata, T., Hasegawa, H. (2007) Intranasal immunization with H5N1 vaccine plus Poly I: Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge. Microbes Infect. 9, 1333-1340.
216. Stevceva, L. (2011) Toll-like receptor agonists as adjuvants for HIV vaccines. Curr. Med. Chem. 18, 5079-5082.
217. Casella, C. R., Mitchell, T. C. (2008) Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell. Mol. Life Sci. 65, 3231-3240.
218. Monie, A., Hung, C. F., Roden, R., Wu, T. C. (2008) Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer. Biologics 2, 97-105.
219. Vijay-Kumar, M., Wu, H., Aitken, J., Kolachala, V. L., Neish, A. S., Sitaraman, S. V., Gewirtz, A. T. (2007) Activation of Toll-like receptor 3 protects against DSS-induced acute colitis. Inflamm. Bowel Dis. 13, 856-864.
220. Bhartiya, D., Sklarsh, J. W., Maheshwari, R. K. (1992) Enhanced wound healing in animal models by interferon and an interferon inducer. J. Cell. Physiol. 150, 312-319.
221. Lin, Q., Wang, L., Lin, Y., Liu, X., Ren, X., Wen, S., Du, X., Lu, T., Su, S. Y., Yang, X., Huang, W., Zhou, S., Wen, F., Su, S. B. (2012) Toll-like receptor 3 ligand polyinosinic: polycytidylic acid promotes wound healing in human and murine skin. J. Invest. Dermatol. 132, 2085-2092.
222. Toshchakov, V. U., Basu, S., Fenton, M. J., Vogel, S. N. (2005) Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction. J. Immunol. 175, 494-500.
223. Piao, W., Vogel, S. N., Toshchakov, V. Y. (2013) Inhibition of TLR4 signaling by TRAM-derived decoy peptides in vitro and in vivo. J. Immunol. 190, 2263-2272.
224. Medzhitov, R., Preston-Hurlburt, P., Kopp, E., Stadlen, A., Chen, C., Ghosh, S., Janeway, Jr., C. A. (1998) MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2, 253-258.
225. Muzio, M., Natoli, G., Saccani, S., Levrero, M., Mantovani, A. (1998) The human Toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187, 2097-2101.
226. Mansell, A., Smith, R., Doyle, S. L., Gray, P., Fenner, J. E., Crack, P. J., Nicholson, S. E., Hilton, D. J., O’Neill, L. A., Hertzog, P. J. (2006) Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7, 148-155.
227. O’Neill, L. A., Fitzgerald, K. A., Bowie, A. G. (2003) The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24, 286-290.
228. Häcker, H., Redecke, V., Blagoev, B., Kratchmarova, I., Hsu, L. C., Wang, G. G., Kamps, M. P., Raz, E., Wagner, H., Häcker, G., Mann, M., Karin, M. (2006) Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204-207.
229. Oganesyan, G., Saha, S. K., Guo, B., He, J. Q., Shahangian, A., Zarnegar, B., Perry, A., Cheng, G. (2006) Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439, 208-211.
230. Guo, B., Cheng, G. (2007) Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J. Biol. Chem. 282, 11817-11826.
231. Tseng, P. H., Matsuzawa, A., Zhang, W., Mino, T., Vignali, D. A., Karin, M. (2010) Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat. Immunol. 11, 70-75.
232. Burns, K., Martinon, F., Esslinger, C., Pahl, H., Schneider, P., Bodmer, J. L., Di Marco, F., French, L., Tschopp, J. (1998) MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273, 12203-12209.
233. Opitz, B., Püschel, A., Schmeck, B., Hocke, A. C., Rosseau, S., Hammerschmidt, S., Schumann, R. R., Suttorp, N., Hippenstiel, S. (2004) Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J. Biol. Chem. 279, 36426-36432.
234. Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J., Chen, Z. J. (2001) TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351.
235. Li, S., Strelow, A., Fontana, E. J., Wesche, H. (2002) IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. USA 99, 5567-5572.
236. Adhikari, A., Xu, M., Chen, Z. J. (2007) Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 26, 3214-3226.
237. Häcker, H., Karin, M. (2006) Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, re13.
238. Chang, L., Karin, M. (2001) Mammalian MAP kinase signalling cascades. Nature 410, 37-40.
239. Bruni, D., Sebastia, J., Dunne, S., Schröder, M., Butler, M. P. (2013) A novel IRAK1-IKKe signaling axis limits the activation of TAK1-IKKb downstream of TLR3. J. Immunol. 190, 2844-2856.
240. Jiang, X., Chen, Z. J. (2011) The role of ubiquitylation in immune defence and pathogen evasion. Nat. Rev. Immunol. 12, 35-48.